1025721-12-3

Basic information

• Product Name: 3-chloro-4-(2-fluoro-4-(1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-picolinamide
• Synonyms: 3-chloro-4-(2-fluoro-4-(1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-picolinamide
• CAS NO: 1025721-12-3
• Molecular Weight: 622.754
• Mol File: 1025721-12-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-chloro-4-(2-fluoro-4-(1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-picolinamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-4-(2-fluoro-4-(1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-picolinamide(1025721-12-3)
• EPA Substance Registry System: 3-chloro-4-(2-fluoro-4-(1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-picolinamide(1025721-12-3)

Safety Data

• Hazardous Substances Data: 1025721-12-3(Hazardous Substances Data)

Upstream product

• 726206-53-7 4-iodo-2-oxo-1,2-dihydropyridine-3-carbaldehyde 
• 158669-26-2 4-iodo-2-methoxynicotinaldehyde 
• 1025721-07-6 1-(4-fluorophenyl)-4-iodo-2-oxo-1,2-dihydropyridine-3-carbaldehyde 
• 1025721-01-0 4-(4-amino-2-fluorophenoxy)-3-chloropyridine-2-carboxamide 
• 1025720-99-3 3,4-dichloropyridine-2-carboxamide 
• 959578-03-1 3,4-dichloropyridine-2-carboxylic acid 
• 55934-00-4 3,4-dichloropyridine 
• 1025721-21-4 1-(4-fluoro-phenyl)-4-iodo-2-oxo-1,2-dihydro-pyridine-3-carbonyl chloride 

Downstream Products

• 1025721-14-5 3-chloro-4-(4-(4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamido)-2-fluorophenoxy)picolinamide 
• 1025720-94-8 BMS-777607 

Relevant articles and documents

PHOSPHONATE CONJUGATES AND USES THEREOF

Phosphonate conjugates, preferably, bisphosphonate conjugates; methods of inhibiting Ron receptor tyrosine kinase and methods of treatment of bone destruction due to cancer or other conditions utilizing the provided phosphonate conjugates.

PYRIDINONE COMPOUNDS

The invention is directed to pyridinone compounds useful for modulating Met kinase, having the following structure: and is further directed to pharmaceutical compositions comprising the compound; and methods for treating proliferative diseases, such as ca